KLF4 and breast carcinoma: In 414 breast cancer cases, both KLF4 and SLC7A11 mRNA levels were negatively related to patients’ post progression survival (PPS) (Figure 4A); that is, the higher the KLF4 or SLC7A11 mRNA expression level, the lower the survival rate after progression.